Negative impact of IFN-γ on early host immune responses to retroviral infection

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2521-2529

  Duley, Amanda K ^a   Ploquin, Mickaël J Y ^b,c   Eksmond, Urszula ^b   Ammann, Christoph G ^a   Messer, Ronald J ^a   Myers, Lara ^a   Hasenkrug, Kim J ^a   Kassiotis, George ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE ACTIVATION; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FRIEND LEUKEMIA VIRUS; GERMINAL CENTER; INNATE IMMUNITY; LACTIC DEHYDROGENASE TOGAVIRUS; MIXED INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; VIRUS CELL INTERACTION;

ADAPTIVE IMMUNITY; ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; FRIEND MURINE LEUKEMIA VIRUS; INTERFERON-GAMMA; LACTATE DEHYDROGENASE-ELEVATING VIRUS; LEUKEMIA VIRUS, MURINE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, CONGENIC; MICE, INBRED A; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; RETROVIRIDAE INFECTIONS; SPLEEN FOCUS-FORMING VIRUSES; TUMOR VIRUS INFECTIONS;

EID: 84865425118     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201125     Document Type: Article

References (49)

1. Virgin, H. W., E. J. Wherry, and R. Ahmed. 2009. Redefining chronic viral infection. Cell 138: 30-50.
2. Welsh, R. M., J. W. Che, M. A. Brehm, and L. K. Selin. 2010. Heterologous immunity between viruses. Immunol. Rev. 235: 244-266.
3. Oldstone, M. B. 2009. Anatomy of viral persistence. PLoS Pathog. 5: e1000523.
4. Friend, C. 1957. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exp. Med. 105: 307-318.
5. Plagemann, P. G., R. R. Rowland, C. Even, and K. S. Faaberg. 1995. Lactate dehydrogenase-elevating virus: an ideal persistent virus? Springer Semin. Immunopathol. 17: 167-186.
6. Kabat, D. 1989. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 148: 1-42.
7. Li, J. P., A. D. D'Andrea, H. F. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343: 762-764.
8. Hasenkrug, K. J. 1999. Lymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant mice. J. Virol. 73: 6468-6473.
9. Hasenkrug, K. J., and U. Dittmer. 2007. Immune control and prevention of chronic Friend retrovirus infection. Front. Biosci. 12: 1544-1551.
10. Plagemann, P. G., and V. Moennig. 1992. Lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus: a new group of positive-strand RNA viruses. Adv. Virus Res. 41: 99-192.
11. Riley, V. 1963. Enzymatic determination of transmissible replicating factors associated with mouse tumors. Ann. N. Y. Acad. Sci. 100: 762-790.
12. Robertson, S. J., C. G. Ammann, R. J. Messer, A. B. Carmody, L. Myers, U. Dittmer, S. Nair, N. Gerlach, L. H. Evans, W. A. Cafruny, and K. J. Hasenkrug. 2008. Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus. J. Virol. 82: 408-418.
13. Pike, R., A. Filby, M. J. Ploquin, U. Eksmond, R. Marques, I. Antunes, K. Hasenkrug, and G. Kassiotis. 2009. Race between retroviral spread and CD4+ T-cell response determines the outcome of acute Friend virus infection. J. Virol. 83: 11211-11222.
14. Marques, R., I. Antunes, U. Eksmond, J. Stoye, K. Hasenkrug, and G. Kassiotis. 2008. B lymphocyte activation by coinfection prevents immune control of friend virus infection. J. Immunol. 181: 3432-3440.
15. Müller, U., U. Steinhoff, L. F. Reis, S. Hemmi, J. Pavlovic, R. M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
16. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259: 1742-1745.
17. Kitamura, D., J. Roes, R. Kühn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
18. Robertson, M. N., M. Miyazawa, S. Mori, B. Caughey, L. H. Evans, S. F. Hayes, and B. Chesebro. 1991. Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting. J. Virol. Methods 34: 255-271.
19. Schepers, K., M. Toebes, G. Sotthewes, F. A. Vyth-Dreese, T. A. Dellemijn, C. J. Melief, F. Ossendorp, and T. N. Schumacher. 2002. Differential kinetics of antigen-specific CD4+ and CD8+ T cell responses in the regression of retrovirus-induced sarcomas. J. Immunol. 169: 3191-3199.
20. Cobbold, S. P., and H. Waldmann. 1984. Therapeutic potential of monovalent monoclonal antibodies. Nature 308: 460-462.
21. Marques, R., A. Williams, U. Eksmond, A. Wullaert, N. Killeen, M. Pasparakis, D. Kioussis, and G. Kassiotis. 2009. Generalized immune activation as a direct result of activated CD4+ T cell killing. J. Biol. 8: 93.
22. Ammann, C. G., R. J. Messer, K. E. Peterson, and K. J. Hasenkrug. 2009. Lactate dehydrogenase-elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells. PLoS ONE 4: e6105.
23. Stromnes, I. M., U. Dittmer, T. N. Schumacher, K. Schepers, R. J. Messer, L. H. Evans, K. E. Peterson, B. Race, and K. J. Hasenkrug. 2002. Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice. J. Virol. 76: 2225-2232.
24. Antunes, I., M. Tolaini, A. Kissenpfennig, M. Iwashiro, K. Kuribayashi, B. Malissen, K. Hasenkrug, and G. Kassiotis. 2008. Retrovirus-specificity of regulatory T cells is neither present nor required in preventing retrovirus-induced bone marrow immune pathology. Immunity 29: 782-794.
25. Zelinskyy, G., K. K. Dietze, Y. P. Hüsecken, S. Schimmer, S. Nair, T. Werner, K. Gibbert, O. Kershaw, A. D. Gruber, T. Sparwasser, and U. Dittmer. 2009. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood 114: 3199-3207.
26. Hasenkrug, K. J., and B. Chesebro. 1997. Immunity to retroviral infection: the Friend virus model. Proc. Natl. Acad. Sci. USA 94: 7811-7816.
27. Harrington, L. E., M. Galvan, L. G. Baum, J. D. Altman, and R. Ahmed. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191: 1241-1246.
28. Masopust, D., K. Murali-Krishna, and R. Ahmed. 2007. Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: it is even bigger than we thought. J. Virol. 81: 2002-2011.
29. Hogan, R. J., E. J. Usherwood, W. Zhong, A. A. Roberts, R. W. Dutton, A. G. Harmsen, and D. L. Woodland. 2001. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166: 1813-1822.
30. Dietze, K. K., G. Zelinskyy, K. Gibbert, S. Schimmer, S. Francois, L. Myers, T. Sparwasser, K. J. Hasenkrug, and U. Dittmer. 2011. Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc. Natl. Acad. Sci. USA 108: 2420-2425.
31. Onami, T. M., L. E. Harrington, M. A. Williams, M. Galvan, C. P. Larsen, T. C. Pearson, N. Manjunath, L. G. Baum, B. D. Pearce, and R. Ahmed. 2002. Dynamic regulation of T cell immunity by CD43. J. Immunol. 168: 6022-6031.
32. Chen, W., H. Qin, B. Chesebro, and M. A. Cheever. 1996. Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors. J. Virol. 70: 7773-7782.
33. Coutelier, J. P., P. G. Coulie, P. Wauters, H. Heremans, and J. T. van der Logt. 1990. In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J. Virol. 64: 5383-5388.
34. Coutelier, J. P., and J. Van Snick. 1985. Isotypically restricted activation of B lymphocytes by lactic dehydrogenase virus. Eur. J. Immunol. 15: 250-255.
35. Yamaguchi, S., M. Hasegawa, T. Suzuki, H. Ikeda, S. Aizawa, K. Hirokawa, and M. Kitagawa. 2003. In vivo distribution of receptor for ecotropic murine leukemia virus and binding of envelope protein of Friend Murine leukemia virus. Arch. Virol. 148: 1175-1184.
36. Dittmer, U., B. Race, K. E. Peterson, I. M. Stromnes, R. J. Messer, and K. J. Hasenkrug. 2002. Essential roles for CD8+ T cells and gamma interferon in protection of mice against retrovirus-induced immunosuppression. J. Virol. 76: 450-454.
37. Santiago, M. L., R. L. Benitez, M. Montano, K. J. Hasenkrug, and W. C. Greene. 2010. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. J. Immunol. 185: 1114-1123.
38. Chesebro, B., and K. Wehrly. 1979. Identification of a non-H-2 gene (Rfv-3) influencing recovery from viremia and leukemia induced by Friend virus complex. Proc. Natl. Acad. Sci. USA 76: 425-429.
39. González-Navajas, J. M., J. Lee, M. David, and E. Raz. 2012. Immunomodulatory functions of type I interferons. Nat. Rev. Immunol. 12: 125-135.
40. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15: 749-795.
41. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon gamma is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005.
42. Lohman, B. L., and R. M. Welsh. 1998. Apoptotic regulation of T cells and absence of immune deficiency in virus-infected gamma interferon receptor knockout mice. J. Virol. 72: 7815-7821.
43. Sercan, O., G. J. Hämmerling, B. Arnold, and T. Schüler. 2006. Innate immune cells contribute to the IFN-gamma-dependent regulation of antigen-specific CD8+ T cell homeostasis. J. Immunol. 176: 735-739.
44. Whitmire, J. K., J. T. Tan, and J. L. Whitton. 2005. Interferon-gamma acts directly on CD8+ T cells to increase their abundance during virus infection. J. Exp. Med. 201: 1053-1059.
45. Remakus, S., and L. J. Sigal. 2011. Gamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response. J. Virol. 85: 12578-12584.
46. Zelinskyy, G., L. Myers, K. K. Dietze, K. Gibbert, M. Roggendorf, J. Liu, M. Lu, A. R. Kraft, V. Teichgräber, K. J. Hasenkrug, and U. Dittmer. 2011. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J. Immunol. 187: 3730-3737.
47. Purdy, A., L. Case, M. Duvall, M. Overstrom-Coleman, N. Monnier, A. Chervonsky, and T. Golovkina. 2003. Unique resistance of I/LnJ mice to a retrovirus is due to sustained interferon gamma-dependent production of virus-neutralizing antibodies. J. Exp. Med. 197: 233-243.
48. Schijns, V. E., B. L. Haagmans, E. O. Rijke, S. Huang, M. Aguet, and M. C. Horzinek. 1994. IFN-gamma receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153: 2029-2037.
49. Markine-Goriaynoff, D., J. T. van der Logt, C. Truyens, T. D. Nguyen, F. W. Heessen, G. Bigaignon, Y. Carlier, and J. P. Coutelier. 2000. IFN-gamma-independent IgG2a production in mice infected with viruses and parasites. Int. Immunol. 12: 223-230.